- Guide to PHARMACOLOGY
Compound class: Endogenous peptide in human, mouse or rat
Comment: IL-9 is a pleiotropic cytokine. Th9 cells and/or the IL-9/IL-9 receptor pathway are potential targets for pharmacological intervention in atopic diseases such as asthma and ulcerative colitis.
1. Kaplan MH, Hufford MM, Olson MR. (2015)
The development and in vivo function of T helper 9 cells.
Nat Rev Immunol, 15 (5): 295-307. [PMID:25848755]
2. Reed JL, Wu H, Tang Y, Davies J, Watkins JD. (2008)
Recombinant IL-9 antibodies.
Patent number: US7354584 B2. Assignee: Medimmune, Inc.. Priority date: 11/04/2003. Publication date: 08/04/2008.